FUJIFILM SonoSite, Inc., is the innovator and world leader in
bedside and point-of-care ultrasound, and an industry leader in ultra
high-frequency micro-ultrasound technology. Headquartered near Seattle,
the company is represented by 26 subsidiaries and a global distribution
network in over 100 countries. SonoSite’s portable, compact systems are
expanding the use of ultrasound across the clinical spectrum by
cost-effectively bringing high-performance ultrasound to the point of
patient care. For more information, go to: www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous
innovation and leading-edge products to a broad spectrum of industries,
including electronic imaging, digital printing equipment, medical
systems, life sciences, graphic arts, flat panel display materials, and
office products, based on a vast portfolio of digital, optical, fine
chemical and thin film coating technologies. The company was among the
top 10 companies around the world granted U.S. patents in 2012, and in
the year ended March 31, 2013, had global revenues of $26.7 billion*.
Fujifilm is committed to environmental stewardship and good corporate
citizenship. For more information, please visit www.fujifilmholdings.com.
* At an exchange rate of 83 yen to the dollar.
All product and company names herein may be trademarks of their
Clinical Evidence and Sources:
EY, Dick A, Perencevich EN, et al. (2011) Central Line Bundle
Implementation in US Intensive Care Units and Impact on Bloodstream
Infections. PLoS ONE 6(1): e15452. doi:10.1371/journal.pone.0015452
S-Y, Ling Q, et al. Real-time two-dimensional ultrasound guidance for
central venous cannulation: A meta-analysis. Anesthesiology 2013 Feb;
FUJIFILM SonoSite, Inc.
Lisa Ault, 516-282-4590
Source: FUJIFILM SonoSite, Inc.